» Authors » Daniel R Hoekman

Daniel R Hoekman

Explore the profile of Daniel R Hoekman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 204
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Helderman N, Andini K, van Leerdam M, van Hest L, Hoekman D, Ahadova A, et al.
J Mol Diagn . 2023 Dec; 26(2):106-114. PMID: 38061582
Screening for Lynch syndrome (LS) in colorectal cancer (CRC) and endometrial cancer patients generally involves immunohistochemical staining of the mismatch repair (MMR) proteins. In case of MLH1 protein loss, MLH1...
2.
van der Laan L, Hoekman D, Wortelboer E, Mannens M, Kooper A
Mol Cytogenet . 2023 Nov; 16(1):34. PMID: 38031124
In this case report, we describe a rare prenatal finding of a small marker chromosome. This marker chromosome corresponds to an inverted duplication of the 13q region 13q31.1q34 (or 13q31.1 ...
3.
Aelvoet A, Hoekman D, Redeker B, Weegenaar J, Dekker E, van Noesel C, et al.
Fam Cancer . 2022 Jun; 22(1):49-54. PMID: 35675019
Biallelic MSH3 germline variants are a rare cause of adenomatous polyposis as yet reported in two small families only. We describe the phenotype of a third family, the largest thus...
4.
Strik A, Lowenberg M, Mould D, Berends S, Ponsioen C, van den Brande J, et al.
Scand J Gastroenterol . 2020 Dec; 56(2):145-154. PMID: 33290108
Objectives: Loss of response (LOR) to infliximab (IFX) remains a challenge in the management of inflammatory bowel diseases (IBD). Proactive dosing strategies to achieve and maintain predefined IFX trough levels...
5.
Hoekman D, Vlieger A, Stokkers P, Mahhmod N, Rietdijk S, de Boer N, et al.
J Crohns Colitis . 2020 Nov; 15(7):1106-1113. PMID: 33245332
Background And Aims: Many inflammatory bowel disease [IBD] patients in remission have persisting symptoms, compatible with irritable bowel syndrome [IBS-type symptoms]. We aimed to compare the effectiveness of gut-directed hypnotherapy...
6.
Hoekman D, Lowenberg M, van den Brink G, Ponsioen C, Benninga M, DHaens G
Eur J Gastroenterol Hepatol . 2019 Oct; 32(1):38-44. PMID: 31651651
Background: Patient reported outcomes are important in Crohn's disease. In this prospective cohort, we investigated the performance of the Bristol Stool Form Scale (BSFS) and a visual analog scale (VAS)...
7.
Hoekman D, Stibbe J, Baert F, Caenepeel P, Vergauwe P, De Vos M, et al.
J Crohns Colitis . 2018 Feb; 12(5):517-524. PMID: 29401297
Background And Aims: Long-term outcomes of early combined immunosuppression [top-down] compared to conventional management [step-up] in recently diagnosed Crohn's disease [CD] are unknown. We aimed to investigate long-term outcomes of...
8.
Bekkali N, Hoekman D, Liem O, Bongers M, van Wijk M, Zegers B, et al.
J Pediatr Gastroenterol Nutr . 2017 Sep; 66(1):10-15. PMID: 28906317
Objective: The long-term efficacy and safety of polyethylene glycol (PEG) in constipated children are unknown, and a head-to-head comparison of the different PEG formulations is lacking. We aimed to investigate...
9.
Jairath V, Zou G, Parker C, MacDonald J, AlAmeel T, Al Beshir M, et al.
Cochrane Database Syst Rev . 2017 Sep; 9:CD011572. PMID: 28886205
Background: It is important to minimize placebo rates in randomised controlled trials (RCTs) to efficiently detect treatment differences between interventions. Historically, high placebo rates have been observed in clinical trials...
10.
Hoekman D, Zeevenhooven J, DHaens G, Benninga M
Eur J Gastroenterol Hepatol . 2017 Jun; 29(9):1086-1090. PMID: 28639969
Objective: Symptoms of irritable bowel syndrome (IBS) are common in inflammatory bowel disease (IBD) and are believed to reflect ongoing inflammation. Consequently, a low prevalence of IBS-type symptoms in IBD...